CYP1A1 and laryngeal carcinoma: Another study70 showed that the m2/m2 genotype of CYP1A1 MspI polymorphism had a significantly elevated risk in oral cancer patients, but there was no significant relationship between this polymorphism and pharyngeal and laryngeal cancers that one review80 confirmed it.